Farms.com Home   News

Saskatchewan Farmland Values Show Modest Growth

According to the report, the national average for farmland values fell from a 6.6 % increase in 2018 to a 3% increase in the first half this year.
 
J.P. Gervais, FCC’s Senior Market Analyst, says farmland values in Saskatchewan saw modest growth of 2.9%.
 
“If you’re looking at the different regions of Saskatchewan, whether it’s North, South, East or West the average increases may get a little bit higher in the western side of the Province than the eastern side but it’s quite consistent that just is around that 3% range.”
 
He says farm receipts are expected to be a little bit lower with the uncertainty in the markets.
 
“To me, that makes sense that this is slowing down. So the markets holding strong, but we’re seeing a lot less robust increases and more modest increases in farmland values across the entire province.”
 
He notes the fact that farmland values have climbed rapidly in the past; which may be giving some producers reason to pause when it comes to investing in land.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.